EU Regulators Warn of Counterfeit Copies of Cancer Drug Herceptin
EU regulators have issued a warning that several batches of the cancer medicine Herceptin (trastuzumab) have been “tampered with,” falsified and reintroduced into the supply chain, potentially putting patients at risk.
High-cost cancer medications like Herceptin have become an increasingly tempting target for thieves and counterfeiters in recent years. While they lack the ready market that some drugs like Viagra have, their extraordinary cost means extraordinary paydays. US officials warned of a similar scare in February 2012, when counterfeit copies of Roche’s Avastin (bevacizumab) were found to have infiltrated the US supply chain. Another batch of the counterfeit drug was found in April 2012.
In the wake of those findings, FDA went after more than a dozen physicians, who were blamed for purchasing the Avastin from unauthorized suppliers in the pursuit of higher profit margins.
Related Posts
Customs spots June surge in smuggled goods.
The trade value of brand-name products smuggled into Thailand surged in June,...
Doncaster man punished for dealing in illicit tobacco
A Doncaster man has been punished for his part in an underworld operation dealing...
Fake Medicine Sale In Odisha: Glenmark Issues Advisory On How To Know Originality
Bhubaneswar: In the wake of distribution and sale of its duplicate products in...
ECI seizes cash, liquor and other material worth about ₹302 crore since March 1 in Andhra Pradesh
The Election Commission of India (ECI) has seized cash, liquor and other...